A Comparison Study of Apadenoson and Adenosine to Treadmill Exercise Stress.

This study has been terminated.
(Business decision to end program)
Sponsor:
Information provided by:
Forest Laboratories
ClinicalTrials.gov Identifier:
NCT00380198
First received: September 21, 2006
Last updated: January 18, 2011
Last verified: April 2008

September 21, 2006
January 18, 2011
July 2006
November 2006   (final data collection date for primary outcome measure)
Agreement between MPI Summed Stress Scores for extent and severity of disease
Same as current
Complete list of historical versions of study NCT00380198 on ClinicalTrials.gov Archive Site
Comparison of imaging data to 6 month event data or angiography
Same as current
Not Provided
Not Provided
 
A Comparison Study of Apadenoson and Adenosine to Treadmill Exercise Stress.
A Randomized, Double-Blind Comparison of Apadenoson and Adenosine to Treadmill Exercise Stress for Single-Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)

The purpose of this clinical research study is to compare Apadenoson and adenosine to treadmill exercise stress SPECT MPI

Not Provided
Interventional
Phase 3
Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Crossover Assignment
Masking: Double-Blind
Primary Purpose: Diagnostic
Coronary Artery Disease
Drug: Apadenoson
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Terminated
1500
November 2006
November 2006   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Clinically appropriate for exercise stress testing

Exclusion Criteria:

  • Contraindication to adenosine stress or inability to perform treadmill exercise test
Both
18 Years and older
Not Provided
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00380198
BMS068645-305, EudraCT #2006-002222-31
Not Provided
Amy Lankford, PhD, Sr. Manager, PGxHealth, LLC
Forest Laboratories
Not Provided
Study Director: Robert Mittleman, MD Bristol-Myers Squibb
Forest Laboratories
April 2008

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP